GlassScriptPhysician profile
Irina V Swing
NPI 1225666753
$3,856.03
in general payments reported to CMS, 2019-2025
15 companies · $1,391 in 2025
The $1,391 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $520 · 2024: $1,945 · 2025: $1,391.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,829 · Education: $26.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,829.30 |
| Education | $26.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $670.60 | 2023-2025 | Mavenclad, Mavenclad |
| Abbvie INC. | $585.17 | 2023-2025 | |
| Lilly USA, LLC | $450.30 | 2024-2025 | Kisunla, Amyvid |
| Alexion Pharmaceuticals, INC. | $380.26 | 2024-2025 | Ultomiris |
| Biogen, INC. | $341.85 | 2024-2025 | Vumerity, Leqembi |
| Eisai INC. | $331.73 | 2024-2025 | |
| Argenx US, INC. | $223.61 | 2023-2024 | Vyvgart Hytrulo, Vyvgart |
| Lundbeck LLC | $173.22 | 2023-2024 | Vyepti |
| Neurelis, INC. | $154.65 | 2024-2025 | Valtoco |
| Sk Life Science, INC. | $153.63 | 2024 | Xcopri |
| Otsuka America Pharmaceutical, INC. | $125.00 | 2024 | Rexulti |
| Pfizer INC. | $116.25 | 2024-2025 | |
| Genentech USA, INC. | $86.04 | 2024-2025 | Ocrevus Zunovo |
| Ucb, INC. | $42.81 | 2025 | Rystiggo |
| Neurocrine Biosciences, INC. | $20.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irina Swing listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.